David Hallett
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Hallett
David Hallett is recorded as CTO and Board Member at Recursion Pharmaceuticals, Inc. (RXRX). Recursion Pharmaceuticals, Inc. reported in an 8-K filed August 8, 2024 that David Hallett was appointed Chief Scientific Officer.
“David Hallett, Ph.D., Interim Chief Executive Officer & Chief Scientific Officer of Exscientia, plans to join the combined company as Chief Scientific Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-08–present
-
Current
2024-08-08–present
-
Recursion Pharmaceuticals, Inc. (RXRX)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Recursion Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher C. Gibson CEO, Board Member
- Najat Khan CEO
- Najat Khan, Ph.D. CEO, Board Member
- Christopher Gibson, Ph.D. Chairman
- Robert Hershberg, M.D., Ph.D. Chairman
- Ben Taylor CFO
- Kristen Rushton COO
- Tina Marriott COO
- Blake Borgeson Board Member
- Dean Y. Li Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.